Publications of Udo Reichl

Grabherr, R. & Reichl, U. (2015)Can modern vaccine technology pursue the success of traditional vaccine manufacturing?Biotechnology Journal, 10(5), 657–658WILEY-VCH Verlag GmbH & Co. KGaA, Weinheimdoi: 10.1002/biot.201500184.

Kupke, S. Y., Frensing, T., Zmora, P., & Reichl, U. (2020)Protective Interfering Nucleic Acid Molecule And Virus - Like Particle, Virsl Vector, or Virus Particle Containing the same as well as Pharmaceutical Composition Containing the Protective Interfering Nucleic Acid and its use.

Tapia, F., Genzel, Y., & Reichl, U. (2019)Plug Flow Tubular Bioreactor , System Containing the same and Method for Production of Virus.

Wolff, M. W., Pieler, M., Reichl, U., & Marichal-Gallardo, P. (2019)Method for the Separation of Virus Compositions Including Depletion and Purification thereof.

Hellwig, P., Dittrich, A., Heyer, R., Reichl, U., & Benndorf, D. (2024)Detection, isolation and characterisation of phage-host complexes using BONCAT and click chemistrybioRxivdoi: 10.1101/2024.02.13.580147.

Karsten, C. B., Buettner, F. F. R., Cajic, S., Nehlmeier, I., Roshani, B., Klippert, A., Sauermann, U., Stolte-Leeb, N., Reichl, U., Gerardy-Schahn, R., Rapp, E., Stahl-Hennig, C., & Pöhlmann, S. (2024)Macrophage- and CD4+ T cell-derived SIV differ in glycosylation, infectivity and neutralization sensitivitybioRxivdoi: 10.1101/2024.01.02.572735.

Zuniga-Banuelos, F. J., Lemke, G., Hoffmann, M., Reichl, U., & Rapp, E. (2024)Immunoglobulin A Carries Sulfated N glycans Primarily at the Tailpiece Site – An Oxonium-Ion-Guided Approach for Site-Specific N glycan IdentificationbioRxivdoi: 10.1101/2024.06.06.597690.

Zuniga-Banuelos, F. J., Hoffmann, M., Reichl, U., & Rapp, E. (2023)New avenues for human blood plasma biomarker discovery via improved in-depth analysis of the low-abundant N glycoproteomebioRxivdoi: 10.1101/2023.10.22.562384 .

Pelz, L., Rüdiger, D., Alnaji, F. G., Genzel, Y., Brooke, C. B., Kupke, S. Y., & Reichl, U. (2021)Semi-continuous propagation of influenza A virus and its defective interfering particles: analyzing the dynamic competition to select candidates for antiviral therapybioRxivdoi: 10.1101/2021.02.08.430251 .

Prerna , A., Bdeir, N., Gärtner, S., Reiter, S., Pelz, L., Felgenhauer, U., Reichl, U., Ludwig, S., Weber, F., Hoffmann, M., Winkler, M., & Pöhlmann , S. (2021)Interferon induction and not replication interference mainly determines anti-influenza virus activity of defective interfering particlesbioRxivdoi: 10.1101/2021.09.20.461172 .

Van Den Bossche, T., Kunath, B. J., Schallert, K., Schäpe, S. S., Abraham, P. E., Armengaud, J., Arntzen, M. Ø., Bassignani, A., Benndorf, D., Fuchs, S., Giannone, R. J., Griffin, T. J., Hagen, L. H., Halder, R., Henry, C., Hettich, R. L., Heyer, R., Jagtap, P., Jehmlich, N., Jensen, M., Juste, C., Kleiner, M., Langella, O., Lehmann, T., Leith, E., May, P., Mesuere, B., Miotello, G., Peters, S. L., Pible, O., Reichl, U., Renard, B. Y., Schiebenhoefer, H., Scryba, A., Tanca, A., Trappe, K., Trezzi, J.-P., Uzzau, S., Verschaffelt, P., von Bergen, M., Wilmes, P., Wolf, M., Martens, L., & Muth, T. (2021)Critical Assessment of Metaproteome Investigation (CAMPI): A Multi-Lab Comparison of Established WorkflowsbioRxivdoi: 10.1101/2021.03.05.433915 .